The stock of Imunon Inc (IMNN) has gone down by -10.60% for the week, with a -12.71% drop in the past month and a -16.62% drop in the past quarter. The volatility ratio for the week is 5.60%, and the volatility levels for the past 30 days are 5.57% for IMNN. The simple moving average for the past 20 days is -12.66% for IMNN’s stock, with a -22.58% simple moving average for the past 200 days.
Is It Worth Investing in Imunon Inc (NASDAQ: IMNN) Right Now?
Company’s 36-month beta value is 1.40.Analysts have differing opinions on the stock, with 3 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for IMNN is 13.91M, and currently, short sellers hold a 7.32% ratio of that floaft. The average trading volume of IMNN on May 13, 2025 was 121.83K shares.
IMNN) stock’s latest price update
The stock price of Imunon Inc (NASDAQ: IMNN) has plunged by -9.06 when compared to previous closing price of 0.82, but the company has seen a -10.60% decline in its stock price over the last five trading sessions. seekingalpha.com reported 2025-05-12 that Imunon, Inc. (NASDAQ:IMNN ) Q1 2025 Earnings Conference Call May 12, 2025 11:00 AM ET Company Participants Peter Vozzo – ICR Healthcare, Investor Relations Stacy Lindborg – President & Chief Executive Officer Douglas Faller – Chief Medical Officer David Gaiero – Interim Chief Financial Officer Conference Call Participants Emily Bodnar – H.C. Wainwright Laura Suriel – Alliance Global Partners Operator Good morning.
IMNN Trading at -17.65% from the 50-Day Moving Average
After a stumble in the market that brought IMNN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -79.67% of loss for the given period.
Volatility was left at 5.57%, however, over the last 30 days, the volatility rate increased by 5.60%, as shares sank -12.93% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -13.29% lower at present.
During the last 5 trading sessions, IMNN fell by -8.73%, which changed the moving average for the period of 200-days by -35.26% in comparison to the 20-day moving average, which settled at $0.8503. In addition, Imunon Inc saw -21.89% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at IMNN starting from Braun Donald P, who purchase 25,000 shares at the price of $1.18 back on Aug 20 ’24. After this action, Braun Donald P now owns 25,597 shares of Imunon Inc, valued at $29,480 using the latest closing price.
Lindborg Stacy, the President and CEO of Imunon Inc, purchase 25,000 shares at $0.98 during a trade that took place back on Aug 15 ’24, which means that Lindborg Stacy is holding 264,166 shares at $24,500 based on the most recent closing price.
Stock Fundamentals for IMNN
Current profitability levels for the company are sitting at:
- -5720.09 for the present operating margin
- 0.25 for the gross margin
The net margin for Imunon Inc stands at -12317.53. The total capital return value is set at 0.72. Equity return is now at value -397.54, with -167.96 for asset returns.
Based on Imunon Inc (IMNN), the company’s capital structure generated 0.69 points at debt to capital in total, while cash flow to debt ratio is standing at -2.84.
Currently, EBITDA for the company is -17.9 million with net debt to EBITDA at -0.24. When we switch over and look at the enterprise to sales, we see a ratio of 1401.57. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.88.
Conclusion
In a nutshell, Imunon Inc (IMNN) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
